Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Askalan, R.
Right arrow Articles by Weiss, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Askalan, R.
Right arrow Articles by Weiss, S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Autism
*Epilepsy
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Prospective Preliminary Analysis of the Development of Autism and Epilepsy in Children With Infantile Spasms

Rand Askalan, PhD,MD

Division of Neurology, The Hospital for Sick Children, Toronto ON, Canada

Mark Mackay, MBBS

Department of Neurology, Royal Children's Hospital, Parkville, Victoria, Australia

Jessica Brian, PhD

Autism Research Un it, Child Development Centre, The Hospital for Sick Children, Toronto, ON, Canada

Hiroshi Otsubo, MD

Division of Neurology, The Hospital for Sick Children, Toronto ON, Canada

Catherine McDermott, MA

Autism Research Un it, Child Development Centre, The Hospital for Sick Children, Toronto, ON, Canada

Susan Bryson, PhD

Autism Research Un it, Child Development Centre, The Hospital for Sick Children, Toronto, ON, Canada

Jennifer Boyd, RN

Division of Neurology, The Hospital for Sick Children, Toronto ON, Canada

Carter Snead, III, MD

Division of Neurology, The Hospital for Sick Children, Toronto ON, Canada

Wendy Roberts, MD

Division of Neurology, The Hospital for Sick Children, Toronto ON, Canada

Shelly Weiss

Division of Neurology, The Hospital for Sick Children, Toronto ON, Canada, shelly.weiss{at}sickkids.ca

The objective of this study was to compare the efficacy of corticotropin (ACTH) versus vigabatrin in treating infantile spasms and to determine which medication has a more favorable long-term outcome in terms of cognitive function, evolution of epilepsy, and incidence of autism. Patients with infantile spasms were included in the study if they were 3 to 16 months old, had hypsarrhythmia, and had no previous treatment with vigabatrin or corticosteroids. Patient evaluation included electroencephalographic and psychometric measures before and after treatment. Patients were stratified based on etiology (idiopathic or symptomatic) and sex and then randomized between the ACTH and vigabatrin treatment groups. Each of the treatment groups received either ACTH or vigabatrin for 2 weeks. At the end of 2 weeks of treatment, patients were considered responders if spasms and hypsarrhythmia resolved. Nonresponders were crossed over and treated with the alternate drug. Nine patients were included in the study. Three patients received ACTH, one of whom was a responder. Six patients received vigabatrin, three of whom were responders. The five nonresponders received both therapies. All patients had some degree of developmental plateau or regression before the initiation of treatment. Four patients with idiopathic infantile spasms showed improved cognitive function following treatment. The remaining five patients remained significantly delayed. Five patients with symptomatic infantile spasms had epilepsy following treatment; three of them were in the autistic spectrum. The small number of infants in this pilot study is insufficient to determine which of the two drugs is more effective. However, the following trends were identified: vigabatrin may be more effective for patients with symptomatic infantile spasms; patients with idiopathic infantile spasms tend to have a better cognitive outcome; and patients with symptomatic infantile spasms tend to develop both epilepsy and autism. (J Child Neurol 2003; 18: 165—170).

Journal of Child Neurology, Vol. 18, No. 3, 165-170 (2003)
DOI: 10.1177/08830738030180030801


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?